Form 8-K - Current report:
SEC Accession No. 0001701478-26-000029
Filing Date
2026-05-13
Accepted
2026-05-12 20:09:52
Documents
13
Period of Report
2026-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aztr-20260513.htm   iXBRL 8-K 28975
2 EX-99.1 aztrpressrelease3312026-ex.htm EX-99.1 94706
6 GRAPHIC image_0a.jpg GRAPHIC 13688
  Complete submission text file 0001701478-26-000029.txt   270341

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aztr-20260513.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aztr-20260513_lab.xml EX-101.LAB 22516
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aztr-20260513_pre.xml EX-101.PRE 13047
17 EXTRACTED XBRL INSTANCE DOCUMENT aztr-20260513_htm.xml XML 2800
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41705 | Film No.: 26970472
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)